COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S - Share repurchase programme
19/06/2018
Bagsværd, Denmark, 19 June 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]
Speakeasy Looks to Expand into German Market -- CFN Media
19/06/2018
SEATTLE, June 19, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]
C-RAD publishes outcome of Employee Warrant Program 2018/2021
19/06/2018
C-RAD has launched a warrant program for its employees. All warrants that were offered to current employees were subscribed for. The Annual Shareholder Meeting decided in May 2018 to issue 100,000 warrants for the [...]
Constitutive meeting of Biohit Oyj’s Board of Directors
19/06/2018
Biohit Oyj Other information disclosed according to the rules of the Exchange June 19, 2018 at 9:30 am local time (EEST) Biohit Oyj’s Board of Directors has in its meeting yesterday elected Mr Osmo Suovaniemi as the [...]
Shire plc: Rule 2.9 Announcement
19/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 19 June 2018 Shire [...]
Medibio Receives TGA Approval
19/06/2018
SYDNEY, Australia and MINNEAPOLIS, June 19, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company )(ASX:MEB)(OTCQB:MDBIF), a mental health technology company, announced today it has received confirmation that [...]
Sanofi appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President, Chief Financial Officer
19/06/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President, Chief Financial Officer Paris - June 19, 2018 - Sanofi has appointed Jean-Baptiste [...]
Sanofi nomme Jean-Baptiste Chasseloup de Chatillon au poste de Vice-Président Exécutif, Directeur financier
19/06/2018
Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Sanofi nomme Jean-Baptiste Chasseloup de Chatillon au poste de Vice-Président Exécutif, Directeur financier Paris - Le 19 juin 2018 - Sanofi vient de [...]
Esperite N.V. secures external financing of up to EUR 5 million to support its commercial activity and development of innovative technologies
19/06/2018
Total investment can reach EUR 7.25 million upon exercise of share subscription warrants Amsterdam, The Netherlands - 19 June 2018 Transaction highlights Potential financing of up to EUR 5 million through private [...]
Sanofi : Sanofi completes its acquisition of Ablynx following the expiration of the Squeeze-out Procedure
19/06/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi completes its acquisition of Ablynx following the expiration of the Squeeze-out Procedure Paris, France and Ghent, Belgium - June 19, 2018 - Sanofi ( [...]
Sanofi : Sanofi finalise l'acquisition d'Ablynx à la suite de l'expiration de la procédure d'offre de reprise
19/06/2018
Communiqué de presse Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi finalise l'acquisition d'Ablynx à la suite de l'expiration de la procédure d'offre de reprise Paris, France et Gand, Belgique - Le 19 juin 2018 - [...]
SANOFI COMPLETES ITS ACQUITISION OF ABLYNX FOLLOWING THE EXPIRATION OF THE SQUEEZE-OUT PROCEDURE
19/06/2018
PARIS, France and GHENT, Belgium - June 19, 2018 - Sanofi (Euronext: SAN; NYSE: SNY) and Ablynx announced today that Sanofi has now acquired all outstanding shares (including shares represented by American Depositary [...]
CH Biotech Announces Grand Opening of Global R&D Innovation Center and Corporate Headquarters
19/06/2018
New Facility Is Taiwan's First International R&D Center Focused on Integrating Plant Health Systems NANTOU CITY, Taiwan, June 18, 2018 (GLOBE NEWSWIRE) -- CH Biotech R&D Co., Ltd. ("CH Biotech"), a leader in [...]
REVA Extends Technological Lead in Bioresorbable Scaffolds With CE Mark Approval of the Full Fantom® Encore Product Line
19/06/2018
SAN DIEGO, June 18, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, today announced it has received CE Mark [...]
BioStem Technologies Inc. Announces Issuance of Drug Enforcement Administration Registration for Qualified Pharma Ingredients
18/06/2018
Pompano Beach, FL, June 18, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a concentration [...]
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
18/06/2018
BOSTON, June 18, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]
Sol-Gel Technologies Initiates Pivotal Phase III Clinical Program for Papulopustular Rosacea
18/06/2018
First subject dosed in pivotal Phase III program evaluating Epsolay ® in subjects with papulopustular rosacea Two Phase III trials expected to enroll a total of 700 subjects Top-line data expected to be reported in 2019 [...]
ObsEva Announces Launch of Proposed Follow-on Public Offering
18/06/2018
Geneva, Switzerland and Boston, MA - June 18, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
Olainfarm Sales In The First Five Months Increase by 2%
18/06/2018
Olaine, June 18, 2018 Olainfarm Sales In The First Five Months Increase by 2% Consolidated Results May and 5 months of 2018 Preliminary consolidated Olainfarm Group sales in May 2018 were 8,67 million euros, which [...]

Pages